An Attempt to Develop a New Treatment Strategy for Rare Refractory Gynecological Malignancies: The Japanese Gynecologic Oncology Group

Platinum-based combination chemotherapy has been a frontline therapeutic strategy for advanced ovarian cancer. Although patients with ovarian high-grade serous carcinoma (HGSC) respond well to the combination therapy, those with relatively rare histologic subtypes, such as mucinous or clear cell car...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigeta, Shogo, Shimada, Muneaki, Suzuki, Shiro, Kajiyama, Hiroaki, Oda, Katsutoshi, Takehara, Kazuhiro, Mandai, Masaki, Aoki, Daisuke, Enomoto, Takayuki, Okamoto, Aikou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627836/
https://www.ncbi.nlm.nih.gov/pubmed/37941704
http://dx.doi.org/10.31662/jmaj.2023-0024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627836/
https://www.ncbi.nlm.nih.gov/pubmed/37941704
http://dx.doi.org/10.31662/jmaj.2023-0024

Ejemplares similares